Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria S Tretiakova

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Clinical Genitourinary Cancer|May 7, 2023
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical CystectomyRishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, et al.
Urologic Oncology|September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort studyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.
Cancer Research Communications|August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted TherapiesHyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
The American Journal of Surgical Pathology|June 8, 2018
Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic PathologistsSean R Williamson, Priya Rao, Ondrej Hes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 5, 2021
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Ondrej Hes, Sean R Williamson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Sean R Williamson, Anthony J Gill, et al.
Journal of Clinical Pathology|January 30, 2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international surveyMahmut Akgul, Sean R Williamson, Dilek Ertoy, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Genitourinary Cancer|May 7, 2023
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical CystectomyRishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, et al.
Urologic Oncology|September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort studyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.
Cancer Research Communications|August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted TherapiesHyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
The American Journal of Surgical Pathology|June 8, 2018
Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic PathologistsSean R Williamson, Priya Rao, Ondrej Hes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 5, 2021
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Ondrej Hes, Sean R Williamson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Sean R Williamson, Anthony J Gill, et al.
Journal of Clinical Pathology|January 30, 2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international surveyMahmut Akgul, Sean R Williamson, Dilek Ertoy, et al.
Pageof 9